254 related articles for article (PubMed ID: 12508749)
1. [Role of ultrasonography-guided prostatic biopsy of hypoechoic areas associated with systematic biopsies in patients with normal and high PSA levels].
Scattoni V; Roscigno M; Raber M; Consonni P; Freschi M; Montorsi F; Pasta A; Colombo R; Nava L; Bua L; Rigatti P
Arch Ital Urol Androl; 2002 Dec; 74(4):273-5. PubMed ID: 12508749
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of small (less than 0.2 cm3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels less than 10 ng/mL.
Fleshner NE; O'Sullivan M; Premdass C; Fair WR
Urology; 1999 Feb; 53(2):356-8. PubMed ID: 9933054
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features of prostate cancer detected by transrectal ultrasonography-guided systematic six-sextant biopsy.
Ito K; Ichinose Y; Kubota Y; Imai K; Yamanaka H
Int J Urol; 1997 Sep; 4(5):474-9. PubMed ID: 9354949
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of prostate specific antigen density and transrectal ultrasonography-guided biopsies in 100 consecutive patients with a negative digital rectal examination and intermediate serum prostate specific antigen levels.
Tarcan T; Ozveri H; Biren T; Türkeri L; Akdas A
Int J Urol; 1997 Jul; 4(4):362-7. PubMed ID: 9256325
[TBL] [Abstract][Full Text] [Related]
5. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
[TBL] [Abstract][Full Text] [Related]
6. Does transrectal color Doppler ultrasound improve the diagnosis of prostate cancer?
Del Rosso A; Di Pierro ED; Masciovecchio S; Galatioto GP; Vicentini C
Arch Ital Urol Androl; 2012 Mar; 84(1):22-5. PubMed ID: 22649956
[TBL] [Abstract][Full Text] [Related]
7. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
[TBL] [Abstract][Full Text] [Related]
8. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen.
Lodding P; Aus G; Bergdahl S; Frösing R; Lilja H; Pihl CG; Hugosson J
J Urol; 1998 Mar; 159(3):899-903. PubMed ID: 9474178
[TBL] [Abstract][Full Text] [Related]
10. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions.
Cornud F; Belin X; Piron D; Chrétien Y; Flam T; Casanova JM; Hélénon O; Méjean A; Thiounn N; Moreau JF
Urology; 1997 May; 49(5):709-15. PubMed ID: 9145975
[TBL] [Abstract][Full Text] [Related]
11. [Early diagnosis of prostatic carcinoma by random biopsies in 60 patients clinically negative but with PSA greater than 8.9 ng/ml].
Bianchi A; Bottanelli A; Baroni G; Rovellini P; Sciaraffia G; Toia G; Marcelli G
Arch Ital Urol Androl; 1997 Dec; 69(5):313-8. PubMed ID: 9477617
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
13. [Ultrasound-guided biopsy: screening of prostate cancer with a single set of 14 systematic biopsies].
Perdonà S; De Sio M; Damiano R; Oliva A; D'Armiento M
Arch Ital Urol Androl; 2000 Dec; 72(4):258-63. PubMed ID: 11221051
[TBL] [Abstract][Full Text] [Related]
14. [Can indexes based on PSA determine which patients should undergo repeated ultrasound-guided transrectal prostatic biopsy? Study on 546 patients who underwent repeated biopsy].
Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; González Galán A; Zuccarino AL; García González R; Cuesta Roca C
Arch Esp Urol; 2002 Dec; 55(10):225-34. PubMed ID: 12611220
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-guided transrectal extended prostate biopsy: a prospective study.
Al-Ghazo MA; Ghalayini IF; Matalka II
Asian J Androl; 2005 Jun; 7(2):165-9. PubMed ID: 15897973
[TBL] [Abstract][Full Text] [Related]
16. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
[TBL] [Abstract][Full Text] [Related]
17. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam).
Roobol MJ; van der Cruijsen IW; Schröder FH
Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973
[TBL] [Abstract][Full Text] [Related]
18. Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions.
Loch T; Eppelmann U; Lehmann J; Wullich B; Loch A; Stöckle M
World J Urol; 2004 Nov; 22(5):357-60. PubMed ID: 15672278
[TBL] [Abstract][Full Text] [Related]
19. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
[TBL] [Abstract][Full Text] [Related]
20. [Transrectal ultrasound-guided prostatic biopsy: contribution of an ultrasound diagnostic unit after ten years of experience].
Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; García González R; Arias Fúnez F; Lennie Zuccarino A; Sanz Mayayo E
Arch Esp Urol; 2006 May; 59(4):397-406. PubMed ID: 16800137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
